Study of CB-183,315 in Participants With Clostridium Difficile Infection
Clinical trial NCT01085591 · COMPLETED
Trial details
- NCT number
- NCT01085591
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-04-13
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.